Abstract
The incidence of breast cancer has increased all over the world, which can be a result of social-demographic changes and access to health-care services. Despite the increase in the incidence of breast cancer, an increase in mortality rate in developed countries has not been observed. Mammography is, currently, the most important method in breast evaluation. Other diagnostic methods, such as ultrasound, magnetic resonance, scintigraphy, tomosynthesis, and PET-CT, are used as auxiliary methods in the diagnosis of breast cancer, and they are chosen according to the characteristics of the lesion that will be evaluated. There are two different levels of approach for breast evaluation, which have an influence on the choice of imaging methods: Asymptomatic patient evaluation for breast cancer screening and symptomatic patient to diagnose either a benign or a malignant tumor. Indications and limits were described here in order to help the surgeon in their decisions and surgical planning.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Veronesi U et al (2005) Breast cancer. Lancet 365:1727–1741
Jemal A et al (2005) Cancer statistic, 2005. CA Cancer J Clin 55:10–30
Myers ER, Moorman P, Gierisch JM et al (2015) Benefits and harms of breast cancer screening: a systematic review. JAMA 314:1615–1634
Feig SA (2014) Screening mammography benefit controversies: sorting the evidence. Radiol Clin North Am 52:455–480
Tabar L, Chen TH, Hsu CY et al (2017) Evaluation issues in the Swedish Two-County trial of breast cancer screening: an historical review. J Med Screen 24:27–33
D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (2013) ACR BI-RADS atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA
Chu KC, Smart CR, Taronev RE (1998) Analysis of breast cancer mortality and stage distribution by age for the health Insurance Plan Clinical Trial. J Natl Cancer Inst 80:1125–1132
Andersson I, Janzon L (1997) Reduced breast cancer mortality in women under age 50: update results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997(22):63–67
Bjurstam N et al (1997) The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer 80:2091–2099
Brown D (2000) Death rates from breast cancer fall by a third. BMJ 321:849
Frisell J et al (1997) Follow-up after 11 years: update of mortality results in the Stockholm Mammographic Screening Trial. Breast Cancer Res Treat 45:263–270
Jackman VP (2002) Screening mammography: controversies and headlines. Radiology 225:323–326
Miller AB et al (1992) Canadian National Breast Screening Study I: breast cancer detection and death rates among women aged 40-49 years. Can Med Assoc J 147:1459–1476
Miller AB et al (1992) Canadian National Breast Screening Study II: breast cancer detection and death rates among women aged 50-59 years. Can Med Assoc J 147:1447–1488
Tabar L et al (1995) Efficacy of breast cancer screening by age: new results from the Swedish two-county trial. Cancer 75:2507–2517
Liberman L (2004) Breast cancer screening with MRI: what are the data for patients at high risk? N Engl J Med 351:497–500
Shapiro S (1977) Evidence on screening for breast cancer from a randomized trial. Cancer 39:2772
Shapiro S, Strax P, Venet L et al (1982) Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69:349–355
Crystal P et al (2003) Using sonography to screen women with mammographically dense breast. AJR 181:177–182
Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination and breast US, and evaluation of factors that influence them: an analysis of 27,825 patients’ evaluations. Radiology 225:165–175
Kriege R et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:425–437
Warner E et al (2004) Surveillance of BRCA2 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1713–1725
Kuhl CK et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familiar risk for breast cancer. J Clin Oncol 23:8469–8476
Riedl CC, Luft N, Bernhart C et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33:1128–1135
Urban LABD, Schaefer MB, Duarte DL et al (2012) Recommendations of Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, Sociedade Brasileira de Mastologia, and Federação Brasileira das Associações de Ginecologia e ObstetrÃcia for imaging screening for breast cancer. Radiol Bras 45:334–339
Moy L, Slanetz PJ, Moore R et al (2002) Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology 225:176–181
Stravos TM et al (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196:123–134
Rahbar H et al (1999) Benign versus malignant solid breast masses: US differentiation. Radiology 213:889–894
Hylton N (2005) Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 23:1678–1684
Kuhl CK et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144
Muller-Schimpfle M et al (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in mr imaging of the breast. Radiology 203:145–149
Nunes LW, Schnall MD, Orel SG et al (1997) Breast MR imaging interpretation model. Radiology 202:833–841
Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881–888
Kuhl CK et al (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101–110
Warner E et al (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clinl Oncol 19:3524–3531
Kriege M, Brekelmans CT, Boetes C et al (2004) Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437
Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476
Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778
Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J Am Med Assoc 292:1317–1325
Sardanelli F, Podo F, D’Agnolo G et al (2007) High breast cancer risk Italian trial. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242:698–715
Lehman CD, Isaacs C, Schnall MD et al (2007) Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244:381–388
Kuhl C, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 20:1450–1457
Lee CH, Dershaw D, Kopens D et al (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7:18–27
Warner E, Yaffe M, Andrews KS et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89
Stomper PC et al (1999) Breast MRI in the evaluation of patients with occult primary breast carcinoma. Breast J 5:230–234
Schorn C et al (1999) MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 9:470–473
Morris E et al (1997) MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205:437–440
Orel S et al (1999) Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212:543–549
Fischer U et al (2004) The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14(10):1725–1731
Kuhl CK, Schmiedel A, Morakkabati N et al (2002) Breast MR imaging of the asymptomatic contralateral breast in the work up or follow-up of patients with unilateral breast cancer. (abstr) Radiology 217[P]:268
Liberman L, Moris EA, Kim CM et al (2003) MR imaging findings in the contralateral breast in women with recently diagnosed breast cancer. AJR 180:333–341
Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet 375:563–571
Tan MP (2009) An algorithm for the integration of breast magnetic resonance imaging into clinical practice. Am J Surg 197:691–694
Sardanelli F et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316
Pickles M et al (2005) Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91:01–10
Rieber A, Brambs HJ, Gabelmann A et al (2002) Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 12:1711–1719
Martincich L et al (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83:67–76
Morrogh M, Morris EA, Liberman L et al (2007) The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge. Ann Surg Oncol 14:3369–3378
Dershaw D (2002) Breast imaging and the conservative treatment of breast cancer. Radiol Clin North Am 40:501–516
Berg WA, Nguyen TK, Middleton MS, Soo MS et al (2002) MR imaging of extra-capsular silicon from breast implant: diagnostic pitfalls. AJR 178:465–472
Kuhl C, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492
Cher DJ, Conwell JA, Mandel JS (2001) MRI for detecting silicone breast implant rupture: meta-analysis and implications. Ann Plast Surg 47:367–380
Hölmich LH et al (2005) The diagnosis of breast-implant rupture: clinical findings compared with findings at magnetic resonance imaging. Ann Plast Surg 54:583–589
Mc Carthy MC, Pusic AL, Kerrigan CL (2008) Silicone breast implants and magnetic resonance imaging screening for rupture: do US Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care? Plast Reconstr Surg 121:1127–1134
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Urban, L., Urban, C. (2019). Breast Imaging in Oncoplastic and Reconstructive Breast Surgery. In: Urban, C., Rietjens, M., El-Tamer, M., Sacchini, V.S. (eds) Oncoplastic and Reconstructive Breast Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-62927-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-62927-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62925-4
Online ISBN: 978-3-319-62927-8
eBook Packages: MedicineMedicine (R0)